| Beta2AR positive | Beta2AR negative | P value |
---|---|---|---|
Age | |||
  ≤ 50 year | 35 | 7 | 0.391 |
  > 50 year | 87 | 26 |  |
Gender | Â | Â | 0.848 |
 Male | 98 | 27 |  |
 Female | 24 | 6 |  |
Hepatitis virus infection | Â | Â | 0.439 |
 HBV | 106 | 29 |  |
 HCV | 4 | 2 |  |
 HBV + HCV | 1 | 1 |  |
 None | 11 | 1 |  |
AFP level | Â | Â | 0.685 |
  ≤ 20ug/L | 58 | 17 |  |
  > 20ug/L | 64 | 16 |  |
Tumor number | Â | Â | 0.154 |
 Solitary | 118 | 30 |  |
 Multiple | 4 | 3 |  |
Tumor size | Â | Â | 0.0001 |
  ≤ 5 cm | 82 | 33 |  |
  > 5 cm | 40 | 0 |  |
TNM stage | Â | Â | 0.795 |
 I | 44 | 12 |  |
 II | 49 | 14 |  |
 III | 22 | 4 |  |
 IV | 7 | 3 |  |
Differentiation | Â | Â | 0.328 |
 Well | 36 | 14 |  |
 Moderate | 58 | 14 |  |
 Poor | 28 | 5 |  |
Post operation treatment | Â | Â | 0.483 |
 None | 77 | 23 |  |
 TACE | 45 | 10 |  |